Lv2
180 积分 2021-07-25 加入
OP0079 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-AND-TOCILIZUMAB CONTROLLED PHASE II TRIAL OF VDJ-001, A HIGH-AFFINITY IL-6R ANTAGONIST ANTIBODY, FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS
3天前
求助中
Soluble interleukin‐6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism
18天前
已完结
Synovial joint-on-a-chip for modeling arthritis: progress, pitfalls, and potential
25天前
已完结
Collagen‐induced arthritis in an outbred group of rhesus monkeys comprising responder and nonresponder animals. Relationship between the course of arthritis and collagen‐specific immunity
1个月前
已完结
Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain
1个月前
已完结
The Major Histocompatibility Complex of Rhesus Monkeys, RhL-A. VII. Identification of Five New Serologically Defined Antigens*
1个月前
已完结
Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region
1个月前
已完结
Rheumatoid arthritis
1个月前
已完结
Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What’s the Difference?
1个月前
已完结
Underpinning IL-6 biology and emphasizing selective JAK blockade as the potential alternate therapeutic intervention for rheumatoid arthritis
1个月前
已完结
皖公网安备34019202002308
